@article{blateauTERTPromoterMutation2020,
  title = {{{TERT Promoter Mutation}} as an {{Independent Prognostic Marker}} for {{Poor Prognosis MAPK Inhibitors-Treated Melanoma}}},
  author = {Blateau, Pauline and Coyaud, {\'E} and Laurent, E. and B{\'e}ganton, Beno{\^i}t and Ducros, Vincent and Chauchard, G{\'e}raldine and Vendrell, J. and Solassol, J.},
  year = {2020},
  journal = {Cancers},
  doi = {10.3390/cancers12082224},
}

@article{vanallenGeneticLandscapeClinical2014,
  title = {The {{Genetic Landscape}} of {{Clinical Resistance}} to {{RAF Inhibition}} in {{Metastatic Melanoma}}},
  author = {Van Allen, Eliezer M. and Wagle, Nikhil and Sucker, Antje and Treacy, Daniel J. and Johannessen, Cory M. and Goetz, Eva M. and Place, Chelsea S. and {Taylor-Weiner}, Amaro and Whittaker, Steven and Kryukov, Gregory V. and Hodis, Eran and Rosenberg, Mara and McKenna, Aaron and Cibulskis, Kristian and Farlow, Deborah and Zimmer, Lisa and Hillen, Uwe and Gutzmer, Ralf and Goldinger, Simone M. and Ugurel, Selma and Gogas, Helen J. and Egberts, Friederike and Berking, Carola and Trefzer, Uwe and Loquai, Carmen and Weide, Benjamin and Hassel, Jessica C. and Gabriel, Stacey B. and Carter, Scott L. and Getz, Gad and Garraway, Levi A. and Schadendorf, Dirk and {on behalf of the Dermatologic Cooperative Oncology Group of Germany (DeCOG)}},
  year = {2014},
  month = jan,
  journal = {Cancer Discovery},
  volume = {4},
  number = {1},
  pages = {94--109},
  issn = {2159-8274},
  doi = {10.1158/2159-8290.CD-13-0617},
}

@article{louveauBaselineGenomicFeatures2019,
  title = {Baseline {{Genomic Features}} in {{BRAFV600-Mutated Metastatic Melanoma Patients Treated}} with {{BRAF Inhibitor}} + {{MEK Inhibitor}} in {{Routine Care}}},
  author = {Louveau, Baptiste and Jouenne, Fanelie and {Reger de Moura}, Coralie and Sadoux, Aurelie and Baroudjian, Barouyr and Delyon, Julie and Herms, Florian and De Masson, Adele and Da Meda, Laetitia and Battistella, Maxime and Dumaz, Nicolas and Lebbe, Celeste and Mourah, Samia},
  year = {2019},
  month = aug,
  journal = {Cancers},
  volume = {11},
  number = {8},
  pages = {E1203},
  issn = {2072-6694},
  doi = {10.3390/cancers11081203},
  langid = {english},
  pmcid = {PMC6721518},
  pmid = {31426590}
}


@article{yanGenomicFeaturesExceptional2019,
  title = {Genomic {{Features}} of {{Exceptional Response}} in {{Vemurafenib}} {$\pm$} {{Cobimetinib-treated Patients}} with {{BRAF V600-mutated Metastatic Melanoma}}},
  author = {Yan, Yibing and Wongchenko, Matthew J. and Robert, Caroline and Larkin, James and Ascierto, Paolo A. and Dr{\'e}no, Brigitte and Maio, Michele and Garbe, Claus and Chapman, Paul B. and Sosman, Jeffrey A. and Shi, Zhen and Koeppen, Hartmut and Hsu, Jessie J. and Chang, Ilsung and Caro, Ivor and Rooney, Isabelle and McArthur, Grant A. and Ribas, Antoni},
  year = {2019},
  month = jun,
  journal = {Clinical Cancer Research: An Official Journal of the American Association for Cancer Research},
  volume = {25},
  number = {11},
  pages = {3239--3246},
  issn = {1557-3265},
  doi = {10.1158/1078-0432.CCR-18-0720},
  langid = {english},
  pmcid = {PMC8083896},
  pmid = {30824584}
}

@article{catalanotti2017pten,
  title={PTEN loss-of-function alterations are associated with intrinsic resistance to BRAF inhibitors in metastatic melanoma},
  author={Catalanotti, Federica and Cheng, Donavan T and Shoushtari, Alexander N and Johnson, Douglas B and Panageas, Katherine S and Momtaz, Parisa and Higham, Catherine and Won, Helen H and Harding, James J and Merghoub, Taha and others},
  journal={JCO Precision Oncology},
  volume={1},
  pages={1--15},
  year={2017},
  publisher={American Society of Clinical Oncology}
}
